Benjamin Davies

Precision measurement of movement could transform outcomes and research for neuromuscular disease. MoveMed is a digital biomarkers and therapeutics startup. Our solutions centre on our patent pending technology, that superimposes interactive games onto background monitoring, across sounds, sensations and actions, to produce high frequency metrics that can diagnose and monitor neuromuscular disease, remotely at the patient's convenience. This can revolutionise clinical care, but also clinical trials. For research, employment, product, or investment opportunities, please contact us.